Get the Stockscreener App
1.9883
0.51%
-0.0183
Seastar Medical Holding Corp stock is traded at $1.9883, with a volume of 120.63K.
It is down -0.51% in the last 24 hours and down -4.39% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
See More
Previous Close:
$1.97
Open:
$2.01
24h Volume:
120.63K
Relative Volume:
0.27
Market Cap:
$14.15M
Revenue:
-
Net Income/Loss:
$-26.23M
P/E Ratio:
-1.6199
EPS:
-1.2274
Net Cash Flow:
$-10.29M
1W Performance:
-12.50%
1M Performance:
-4.39%
6M Performance:
-74.87%
1Y Performance:
-90.48%
1-Day Range:
$1.96
$2.15
1-Week Range:
$1.8048
$3.07
52-Week Range:
$1.50
$42.92
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
1.97 | 14.15M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.81 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.76 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
653.13 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.45 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.84 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Seastar Medical Holding Corp Stock (ICU) Latest News
Quarterly Metrics: Quick and Current Ratios for SeaStar Medical Holding Corp (ICU) - The Dwinnex
How does SeaStar Medical Holding Corp (ICU) change from a tortoise to a hare? - SETE News
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical announces $6M registered direct offering priced ATM - MSN
Investing in SeaStar Medical Holding Corp (ICU): What You Must Know - Knox Daily
Investing in Wimi Hologram Cloud Inc ADR (WIMI) Is Getting More Attractive - Knox Daily
SeaStar Medical Secures $6M Through Equity Agreements - TipRanks
Strategic $6M Capital Raise: SeaStar Medical Secures Institutional Backing with Warrant Sweetener - StockTitan
ICU’s earnings forecast for the current quarter - US Post News
ICU Stock: Exploring SeaStar Medical Holding Corp’s Growth - The InvestChronicle
SeaStar Medical receives Nasdaq public reprimand - MSN
SeaStar Medical Holding Co. (NASDAQ:ICUCW) Sees Significant Growth in Short Interest - Defense World
SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire
SeaStar Medical prices 3.53M shares at $1.70 in registered direct offering - TipRanks
SeaStar Medical secures $6 million in direct offering - MSN
SeaStar Medical Raises Fresh Capital: $6M Strategic Investment Fuels Growth Plans - StockTitan
ICU STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE - GlobeNewswire
SeaStar Medical Expands QUELIMMUNE Treatment to Fifth Major Hospital for Critical Pediatric Care - StockTitan
ICU News Today | Why did SeaStar Medical stock go up today? - MarketBeat
SeaStar Medical (NASDAQ:ICU) Stock Price Down 5.7% – Should You Sell? - Defense World
SeaStar Shares Static Ahead of Drug Trials - Baystreet.ca
SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial - GlobeNewswire
SeaStar Medical says FDA approves feasibility study with SCD-ADULT - Yahoo Finance
SeaStar Medical Gains FDA Approval for Pediatric Device - TipRanks
FDA Approves Feasibility Study with SeaStar Medical’s - GlobeNewswire
SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewswire
Seastar Medical Begins Shipping Quelimmune to A Fourth Hospital Customer - Marketscreener.com
AtriCure (NASDAQ:ATRC) versus SeaStar Medical (NASDAQ:ICU) Critical Contrast - Defense World
Financial Review: Globus Medical (NYSE:GMED) vs. SeaStar Medical (NASDAQ:ICU) - Defense World
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire Inc.
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
ICU stock hits 52-week low at $1.82 amid market challenges - Investing.com
Medical Device Co. Brass Hid SPAC's True Value, Suit Says - Law360
SeaStar Medical Projects Multibillion-Dollar Market - GlobeNewswire
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewswire
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune - Investing.com Nigeria
SeaStar Medical (NASDAQ:ICU) Trading Down 1.6% – What’s Next? - Defense World
SeaStar Medical reduces authorized shares By Investing.com - Investing.com Canada
SeaStar Medical reduces authorized shares - Investing.com
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024 - GlobeNewswire
SeaStar Medical to Present at NobleCon20 Conference on Hyperinflammation Solutions | ICU Stock News - StockTitan
Leading Independent Proxy Advisory Firms ISS and Glass - GlobeNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - Quantisnow
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chung Kevin | Chief Medical Officer |
Sep 30 '24 |
Buy |
4.26 |
1,000 |
4,258 |
9,435 |
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):